PT Eisai Indonesia (PTEI) is a pharmaceutical company established in 1970. Since its establishment, PTEI has been focused on three key therapeutic areas: neurology, gastroenterology, and oncology, delivering prescription medicines that address significant unmet medical needs and support improved patient outcomes.
As part of the Eisai Group, a leading global research and development–based pharmaceutical company headquartered in Japan and established in 1941, PTEI operates in alignment with Eisai’s global expertise in research and development, manufacturing, and ethical pharmaceutical practices. Eisai focuses on the discovery, development, manufacturing, and marketing of prescription medicines, particularly in therapeutic areas where effective treatment options remain limited.
PT Eisai Indonesia's career began in 1968, starting with Eisai Co., Ltd which started marketing operations in Indonesia. Eisai started its business by focusing on the health of patients and their families. Continues to grow and expand in Indonesia until now PT Eisai Indonesia has been contributing to the health of the Indonesian people for more than 50 years.
